8月31日(路透社)——Collplant生物科技有限公司(COLLPLANT BIOTECHNOLOGIES LTD)披露,已签署最终协议,拟收购总部位于以色列的光子计算企业LightSolver。
根据美国证券交易委员会(SEC)的相关文件,Collplant生物科技有限公司将作为本次收购的初始对价,向LightSolver发行370万股股份,约占其总股本的19.7%。
该项交易细节已通过监管文件予以公开披露。
8月31日(路透社)——Collplant生物科技有限公司(COLLPLANT BIOTECHNOLOGIES LTD)披露,已签署最终协议,拟收购总部位于以色列的光子计算企业LightSolver。
根据美国证券交易委员会(SEC)的相关文件,Collplant生物科技有限公司将作为本次收购的初始对价,向LightSolver发行370万股股份,约占其总股本的19.7%。
该项交易细节已通过监管文件予以公开披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.